|
SDF2L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.59050036766473E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.39800000020784E-07 |
| Normal-vs-Stage2 |
1.415240E-01 |
| Normal-vs-Stage3 |
3.68969998998381E-09 |
| Normal-vs-Stage4 |
7.3953954071726E-11 |
| Stage1-vs-Stage2 |
2.527600E-02 |
| Stage1-vs-Stage3 |
1.224420E-03 |
| Stage1-vs-Stage4 |
1.63159999999607E-06 |
| Stage2-vs-Stage3 |
3.237600E-04 |
| Stage2-vs-Stage4 |
1.98790000000004E-05 |
| Stage3-vs-Stage4 |
1.039200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05959999996408E-07 |
| Normal-vs-AfricanAmerican |
2.05519999996184E-06 |
| Normal-vs-Asian |
2.49319999978681E-07 |
| Caucasian-vs-AfricanAmerican |
4.157400E-01 |
| Caucasian-vs-Asian |
7.286600E-01 |
| AfricanAmerican-vs-Asian |
5.197400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.11990000001483E-06 |
| Normal-vs-Female |
4.02830000023613E-07 |
| Male-vs-Female |
5.753400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.30599999984094E-07 |
| Normal-vs-Age(41-60Yrs) |
7.04089997416446E-09 |
| Normal-vs-Age(61-80Yrs) |
1.13509999999373E-06 |
| Normal-vs-Age(81-100Yrs) |
7.856500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.273800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.958600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.099800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.869400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.791600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.448200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.52316003832721E-12 |
| Classical-VS-Follicular |
5.31870003595003E-09 |
| Classical-VS-Other |
7.861000E-01 |
| Classical-VS-Normal |
7.85300002803524E-09 |
| Tall-VS-Follicular |
1.11022302462516E-16 |
| Tall-VS-Other |
5.090100E-02 |
| Tall-VS-Normal |
1.65445435129641E-12 |
| Follicular-VS-Other |
8.707700E-02 |
| Follicular-VS-Normal |
4.316800E-01 |
| Other-VS-Normal |
2.184500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.248400E-04 |
| Normal-vs-N1 |
2.48460000351614E-08 |
| N0-vs-N1 |
2.375800E-04 |
|
|
